PE Hub Staff

NEW YORK — Eyetech Pharmaceuticals, Inc., a privately-held biotechnology company dedicated to discovering, developing and commercializing novel drugs to reduce and prevent vision loss caused by eye disease, announced today that it recently closed a $108.5 million placement of its Series C Preferred Stock to a group of biotechnology and health care institutional investors led […]

SOUTH PLAINFIELD, NJ — Kodeos Communications announced today that it has raised $12 million in Series A equity funding led by Jerusalem Venture Partners (JVP) and Highland Capital Partners. The capital will help Kodeos accelerate development of the industry’s first transponder subsystem for substantially increasing the capacity and distance of transmissions on fiber optic networks. […]

PARAMUS, N.J. — Synaptic Pharmaceutical Corporation (Nasdaq: SNAP) today announced that it will raise up to $41.0 million in a two-stage private financing led by Warburg Pincus. In the first stage of the convertible preferred stock offering that is expected to close later today, the Company will receive $9.4 million. In the second stage, which […]

RESEARCH TRIANGLE PARK, NC — A. M. Pappas & Associates today announced the promotion of Eric W. Linsley to Executive Vice President, Asset Management.

NEW YORK — Patricof & Co. Ventures Inc., as the lead for a syndicate of venture capital firms, announced today an agreement to purchase drug-discovery company, Affymax Research Institute, from GlaxoSmithKline (GSK). The company will be called Affymax, Inc. Under the terms of the purchase, which are subject to a definitive agreement, Patricof & Co. […]

NEW YORK — Warburg Pincus announced today that it completed the first closing of Warburg Pincus Private Equity VIII LP. An aggregate $2.8 billion was committed. The fund, which was launched in March, is expected to eventually close at its $5 billion target capitalization. NEW YORK — ExchangeLab, a leading creator of financial services software […]

NEW YORK — RxCentric Inc., a leading provider of physician relationship management solutions to the pharmaceutical industry, today announced that it has closed $5 million in a Series C financing from existing investors bringing the total capital invested in the company to $21 million. The new funds come amidst solid revenue growth from leading pharmaceutical […]

MILPITAS, CA — Velio Communications, a leader in high bandwidth communications semiconductors, today announced its third round of funding, raising $45 million and bringing the total investment in the company to $95 million. This round is led by Redpoint Ventures. Other investors in this round are Sequoia Capital, Institutional Venture Partners, Global Catalyst Partners, Capital […]

PORTLAND, OR — Fios, the premier provider of electronic discovery, antitrust review, and merger and acquisition due diligence services to law firms and government agencies, announced it has raised $10.1 million in a second round of institutional funding. The international mix of investors was led by Fluke Venture Partners (FVP) and included 3i; Banyan Capital […]

CAMBRIDGE, MA — MPM Capital announced today that it co-led the founding investment in Critical Therapeutics, Inc., a startup biotechnology company focused on the development of therapeutic products for critical care medicine (e.g. acute inflammation, trauma etc). The $10 million Series A financing was co-led with HealthCare Ventures, a leading venture capital firm focused on […]